Joao P. Freitas
Coimbra, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).
Journal: The bone & joint journal
Published: November 30, 2025
What is debridement, antibiotics, and implant retention in orthopaedic oncology? : a global cross-sectional survey of surgeons' practices and opinions.
Journal: Bone & joint open
Published: November 19, 2025
Identifying consensus and areas for future research in chondrosarcoma : a report from the Birmingham Orthopaedic Oncology Meeting.
Journal: The bone & joint journal
Published: January 31, 2025
Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery.
Journal: Diagnostics (Basel, Switzerland)
Published: January 25, 2023
Clinical Impact of Preoperative Biliary Drainage in Patients with Ductal Adenocarcinoma of the Pancreatic Head.
Journal: Diagnostics (Basel, Switzerland)
Published: January 25, 2023
Shear-Wave Elastography Evaluation of Major Salivary Glands in Primary Sjögren's Syndrome.
Journal: ARP rheumatology
Published: September 03, 2022
Ultrasonography Reliability in the Detection of Inflammatory and Structural Abnormalities: An Exercise in Multiple Joints.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: June 23, 2020
Long-Term Response after 94 Cycles of Trabectedin in a Patient with Metastatic Leiomyosarcoma of the Lower Extremity.
Journal: Case reports in oncology
Published: December 09, 2019
Lupus nephritis complicated by cytomegalovirus colitis, aspergillosis and brain abscess.
Journal: Lupus
Published: September 03, 2019
Assessment of the vaccination status in rheumatic disease patients treated with disease-modifying antirheumatic drugs.
Journal: Acta reumatologica portuguesa
Published: July 17, 2019
Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor in rheumatoid arthritis patients who discontinued a first TNF inhibitor.
Journal: Acta reumatologica portuguesa
Published: June 28, 2019
Last Updated: 09/26/2026